CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Income Statement
NASDAQ:CLOV - Nasdaq - US18914F1030 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37B | 1.26B | 3.48B | 1.47B | 0.00 | |||
| Operating Expenses | 1.42B | 1.44B | 3.85B | 2.11B | 6.90M | |||
| Selling, General, and Administrative Expenses | 408.93M | 440.25M | 486.60M | 445.70M | N/A | |||
| Operating Income | -45.46M | -179.56M | -370.90M | -637.00M | -6.90M | |||
| Interest Income/Expense | -517.00K | -4.82M | 8.80M | 62.90M | 100.00K | |||
| Other Income/Expense | 0.00 | 0.00 | 0.00 | -13.70M | N/A | |||
| Non Recurring Items | -288.00K | -25.77M | 23.30M | N/A | N/A | |||
| Income Before Taxes | -46.27M | -210.15M | -338.80M | -587.80M | -6.70M | |||
| Net Income | -43.01M | -213.36M | -338.80M | -587.80M | -6.70M | |||
| EBITDA | -44.13M | -177.05M | -369.71M | -635.75M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.09 | -0.44 | -0.71 | -1.42 | -0.07 | |||
| Non GAAP EPS | -0.09 | -0.44 | -0.74 | -1.27 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -3.14% | -16.93% | -9.74% | -39.93% | N/A | |||
| Operating Profit Margin | -3.32% | -14.24% | -10.67% | -43.27% | N/A | |||
All data in USD